QuickView for Tyrosine-protein kinase SYK/ZAP-70, inter-SH2 domain superfamily (biogroup)

1. NSCLC PC9 cells selected for gefitinib sensitivity or resistance treated with EGF and gefitinib
2. CD45+ blood cells overexpressing MLL-AF4 fusion and activated FLT3
3. Colorectal cancer DLD1 and SW480 cells depleted of β-catenin
4. Embryonic H9 stem cells with heterozygous or homozygous knockout of EZH2
5. Fibrotic and immune pathway signatures in dermal fibroblasts

There were no matches for Tyrosine-protein kinase SYK/ZAP-70, inter-SH2 domain superfamily

There were no clinical trials for Tyrosine-protein kinase SYK/ZAP-70, inter-SH2 domain superfamily